International Clinics
Daily
FDA approves asundexian, the first factor XIa inhibitor to prevent repeat stroke
On 9 November 2026 the FDA approved Bayer's Sunharbo (asundexian).
On 9 November 2026 the FDA approved Bayer's Sunharbo (asundexian).
Nothing more to show